Platform Comparison
Ambrosia vs Cortellis
Clarivate Cortellis is an industry standard for pipeline and regulatory intelligence. Ambrosia delivers the deal economics layer — 1,600+ verified transactions, 14 calculation engines, and pricing starting at $199/month.
Feature Comparison
| Feature | Ambrosia | Cortellis |
|---|---|---|
| Deal Benchmarking | ||
| rNPV Analysis | ||
| Monte Carlo Simulation | ||
| Partner Matching (850+ companies) | ||
| Real-time Deal Intelligence | ||
| PDF/Excel Export | ||
| Competitive Dynamics Engine | ||
| Real Options Valuation | ||
| Pipeline Intelligence (global) | ||
| Regulatory Data | ||
| Patent Analytics | ||
| Deal Terms Database | ||
| API Access | ||
| Pricing Transparency |
Key Differentiators
Deal Economics, Not Just Pipeline Data
Cortellis maps pipelines and regulatory milestones. Ambrosia analyzes the deal terms themselves — what comparable transactions paid in upfronts, how milestone structures break down, and what royalty rates look like by TA and phase.
Real-Time Valuation Engines
Run rNPV, Monte Carlo, real options, tornado sensitivity, and deal waterfall analysis on demand. Cortellis provides static deal summaries without interactive valuation tools.
Transparent, Accessible Pricing
Ambrosia Pro starts at $199/month (annual) with no contract. Cortellis runs $100K-$150K+ per year with per-module pricing, making it inaccessible to smaller biotech teams.
Competitive Dynamics Modeling
Model how competitor pipeline events affect your deal leverage and timing. Ambrosia tracks competitive dynamics in real time — a capability Cortellis does not provide at the deal level.
Pricing Comparison
Cortellis is built for large pharma with enterprise budgets. Ambrosia delivers institutional-grade deal analytics at a fraction of the cost.
Ambrosia Pro
$199/month (annual)
or $299/month month-to-month
- All 14 calculation engines
- Unlimited benchmarks
- PDF/Excel export
- Partner matching
- No contract required
Clarivate Cortellis
~$120K+/year
Per-module enterprise pricing
- Module-based pricing adds up
- Multi-year commitments expected
- Per-seat costs on top
- Sales-led procurement only
Frequently Asked Questions
How does Ambrosia compare to Clarivate Cortellis?
Cortellis is a comprehensive pipeline and regulatory intelligence platform with deep clinical trial data and patent analytics. Ambrosia focuses on deal economics — benchmarking upfronts, milestones, royalties, and running valuation models across 1,500+ verified biopharma transactions with 14 purpose-built engines.
What makes Ambrosia different from Cortellis?
Cortellis covers pipeline intelligence, regulatory data, and patent landscapes. Ambrosia provides deal-specific analytics that Cortellis lacks: Monte Carlo simulation for deal terms, partner matching across 850+ companies, competitive dynamics modeling, real options valuation, and real-time deal intelligence with transparent pricing.
Is Ambrosia cheaper than Cortellis?
Substantially. Ambrosia Pro starts at $199/month (annual) or $299/month with no contract. Cortellis enterprise licenses typically run $100,000-$150,000+ per year depending on modules, with multi-year commitments and per-seat pricing.
Should I use Ambrosia or Cortellis for deal analysis?
For pipeline and regulatory intelligence, Cortellis has deep coverage. For deal-level economics — benchmarking, valuation, partner matching, and competitive dynamics — Ambrosia provides tools that Cortellis does not. Many pharma BD teams use both: Cortellis for pipeline context and Ambrosia for deal structuring and valuation.
The Deal Economics Layer Cortellis Doesn't Cover
Run your asset through Ambrosia's 14 engines and get the deal-level analysis that pipeline databases can't provide.